Germano de Sousa
Founded in 1976, Germano de Sousa is Portugal's largest clinical pathology laboratory group, operating 500+ collection points across continental Portugal and the Azores and serving over one million patients annually through clinical analysis, genetics, anatomical pathology, and specialized diagnostic testing services.
- Company typePrivate
- Founded1976
- HeadquartersCarnide, Portugal
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingServices
What Germano de Sousa does
Germano de Sousa is a Portuguese clinical pathology laboratory group founded in 1976 by Prof. Doutor Germano de Sousa. The group operates three specialized laboratories covering Clinical Pathology, Anatomical Pathology, and Genetics, supported by more than 500 patient collection points across continental Portugal and the Azores, and serves over one million patients annually. The company holds regulatory accreditation through ERS (Entidade Reguladora da Saúde) and the My Green Lab certification, and operates under the Serene® trademark for its non-invasive prenatal test.
The core offering spans routine clinical analysis alongside higher-value specialty diagnostics including the Serene NIPT (non-invasive prenatal testing), Gut Health Premium microbiome panels, Avantect pancreatic cancer screening, Alzheimer's biomarker testing, and COVID-19 testing. Revenue is generated through recurring clinical-pathology, genetics, and anatomical-pathology subscriptions on the patient-facing side, and through professional-services contracts for occupational medicine and home collection services. On the B2B side, the group contracts with Portugal's National Health Service (SNS/ARS), private insurers, and corporate clients.
Distribution is anchored on the 500+ physical collection points and increasingly supplemented by home-collection services and dedicated digital channels per specialty. The company maintains research collaborations with INOV INESC, Nova Medical School, EIA, and V4H, and has participated in EU-funded innovation projects including BE4YOU (€1.25M), a COVID-19 R&D and automation program (€400K), and a Productive Innovation initiative (€160K). The group remains privately held and founder-influenced, with no disclosed PE/VC backing or public-market listing.
Germano de Sousa firmographics
Firmographics- Name
- Germano de Sousa
- Legal name
- Centro de Medicina Laboratorial Germano de Sousa, S.A.
- Website
- https://germanodesousa.com
- Company type
- Private
- Founded year
- 1976
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Founded in 1976, Germano de Sousa is Portugal's largest clinical pathology laboratory group, operating 500+ collection points across continental Portugal and the Azores and serving over one million patients annually through clinical analysis, genetics, anatomical pathology, and specialized diagnostic testing services.
- Ownership category
- akta.pro rank
Germano de Sousa industry classification
Industry- Product category
- Clinical Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), Services-Health Services (8000)
- akta.pro primary industry
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)
- akta.pro secondary industries
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs (HLACAMAH), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)
Keywords
Where Germano de Sousa is headquartered
LocationHeadquarters
- HQ city
- Carnide
- HQ country
- Portugal
- HQ region
- Europe
Offices11 records
Markets served
Germano de Sousa business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Clinical Pathology Testing Services: Core laboratory testing services including blood tests, urine analysis, and other clinical pathology examinations performed at main laboratories and collection points. Revenue generated through patient payments, health insurance reimbursements, and SNS/ARS subsystem agreements.
- Genetic Testing Services: Specialized genetic testing including prenatal screening (Serene® NIPT), hereditary disease testing, and cancer genetic testing.
- Anatomical Pathology Services: Tissue analysis and pathological examination services.
- Occupational Medicine Services: Company occupational health programs including workplace medical examinations and testing for businesses.
- Home Collection Services: At-home sample collection services for patients with mobility limitations or preference for home service.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Standard clinical analysis services |
Go-to-market motion2 records
Distribution channels7 records
Marketing channels8 records
Germano de Sousa product offering
Product offeringCore offering
Germano de Sousa is a Portuguese clinical pathology laboratory group that delivers diagnostic testing services through a national network of more than 500 patient collection points and three specialized laboratories covering clinical pathology, anatomical pathology, and genetics. Core services include routine clinical analyses, prenatal screening (including NIPT), cytogenetics and genomics research, and anatomopathological diagnostics, with additional corporate occupational health testing and partnerships with the Portuguese National Health Service (SNS) and private insurers.
Product overview
Germano de Sousa is a Portuguese clinical laboratory group operating under three core sub-brands: Centro de Medicina Laboratorial (Clinical Pathology Laboratory), Centro de Anatomia Patológica (Anatomical Pathology Laboratory), and Laboratório de Genética (Genetics Laboratory). The group provides a broad portfolio of diagnostic and laboratory services centered on its clinical analysis offering, supplemented by specialized modules including the Gut Health Premium microbiome test, the Serene® non-invasive prenatal screening (NIPT) test, and the Avantect pancreatic cancer early-detection blood test. Services are delivered through a national network of over 500 collection points, with at-home collection, occupational health, and cardiology services as additional modules. Patients access results through online portals and email delivery. The group also operates educational and community initiatives including the No Lab Com and ABC da Genética podcasts, the Programa Escolas school outreach program, a dedicated pregnancy portal (Site da Grávida), and publishes an annual Clinical Cases Book. Founded 50 years ago, the group processes millions of laboratory tests annually serving over one million patients per year.
Differentiator
Problem solved
Functional benefit
Brands
- Centro de Medicina Laboratorial Germano de Sousa: Primary clinical pathology laboratory services division
- Centro de Anatomia Patológica
- Centro de Genética Laboratorial
- Site da Grávida
Products and services
- Clinical pathology laboratory testing
Quantifiable outcome
- >99% sensitivity for trisomy 21, 18, and 13 detection in prenatal screening
- +2 more outcomes
Companies that use Germano de Sousa
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Germano de Sousa technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Germano de Sousa partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered minor and core.
- AgileFactorminorPartnership in BE4YOU project: Predictive platform for health and well-being analysis. Project code LISBOA-01-0247-FEDER-046993 and CENTRO-01-0247-FEDER-046993. Total eligible cost €1,247,331.12 with EU FEDER funding of €707,940.68.
- INOV INESC (INESC INOVAÇÃO)minorPartnership in BE4YOU project: Predictive platform for health and well-being analysis. Project focused on active prevention and promotion of adequate habits and behaviors for adults (+45 years).
- EIA (Entity)minorPartnership in BE4YOU project: Predictive platform for health and well-being analysis. Part of consortium developing innovative services platform for community health.
- SegursalminorPartnership in BE4YOU project: Predictive platform for health and well-being analysis. Part of consortium developing innovative services platform for community health.
- Universidade Nova de Lisboa – Nova Medical School – Faculdade de Ciências Médicas (NMS-FCM)minorCOVID-19 R&D project (LISBOA-01-02B7-FEDER-069202) in collaboration with V4H Association. Total eligible cost €399,641.04 with EU FEDER funding of €319,712.83. Project created national serological screening network and studied SARS-CoV-2 seroprevalence in Portuguese population.
- V4H – Associação para a investigação em valor e inovação tecnológica em saúdeminorCOVID-19 R&D partnership focused on implementing national SARS-CoV-2 exposure screening strategy with high-sensitivity tests and reference laboratory capacity for public health decision support.
- MustelaminorJoint partnership with Mustela for maternal and baby care. The collaboration focuses on caring for expectant mothers, new mothers, and babies in their dermatological care needs. Project includes a dedicated 'Kit Mustela Germano de Sousa' available at select collection points.
- Various Clinics and Pharmaciescore500+ collection points operated through partnerships with independent pharmacies, medical clinics, and healthcare facilities across Portugal. These partners host collection services under the Germano de Sousa brand.
- SNS/ARS (National Health Service and Regional Health Administrations)corePublic healthcare subsystem agreements allowing patients to access Germano de Sousa laboratory services through national health coverage.
- Private Health Insurance CompaniescoreInsurance reimbursement agreements with private health insurance providers for laboratory testing services covered under patient policies.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Germano de Sousa competitors and assessment
Company assessmentBroad incumbents
- Labcorp: Global clinical laboratory and drug development services company with extensive specialty testing capabilities in genetics, oncology, and companion diagnostics. Comparable to Germano de Sousa's advanced test menu (NIPT, ctDNA, biomarker analysis) at significantly larger scale.
- CUF: Largest Portuguese private healthcare group operating hospitals, clinics, and in-house laboratory services. While primarily a hospital operator, CUF's captive diagnostics unit competes with Germano de Sousa for physician referrals, specialty testing, and enterprise occupational health contracts in Portugal.
- Synlab: Europe's largest clinical laboratory operator with pan-European network across 30+ countries, including Iberia. Overlaps directly with Germano de Sousa on routine clinical pathology, genetic testing, and occupational medicine, but at significantly larger scale and with broader specialty test menus.
- Quest Diagnostics: U.S. clinical laboratory leader with growing international footprint through acquired specialty labs. Overlaps with Germano de Sousa on advanced genetic and molecular diagnostics (NIPT, oncology) and serves as a reference point for specialty test pricing and menu development.
- Sonic Healthcare: Global clinical laboratory and radiology operator with European operations including Germany, Switzerland, and the UK. Comparable to Germano de Sousa in clinical pathology scale and specialty testing, but operating as a publicly-listed multinational with broader geographic reach.
- Affidea: European diagnostics and outpatient imaging operator with Iberian footprint. Overlaps with Germano de Sousa on advanced diagnostics and preventive health screening for corporate and public-payor clients across Portugal and Spain.
- Unilabs: Major European clinical diagnostics and imaging network with presence in Portugal and Spain. Competes with Germano de Sousa in routine lab testing, specialty diagnostics, and corporate occupational health, with stronger cross-border integration and capital backing from private equity sponsors.
Direct peers
- Joaquim Chaves Saúde: Portuguese clinical laboratory and diagnostics operator offering clinical analysis, imaging, and occupational medicine services. Most direct domestic peer to Germano de Sousa in Portugal, with overlapping collection networks, hospital partnerships, and patient referral channels.
- Dr. Campos Costa: Portuguese anatomical pathology laboratory specializing in histopathology and cytology. Direct competitor within Germano de Sousa's Anatomic Pathology division, serving overlapping physician referral networks in Portugal.
Emerging players
- Eurofins Genoma: Genetics and molecular diagnostics specialty lab within the Eurofins network, operating across Southern Europe. Direct overlap with Germano de Sousa's genetics division on NIPT, hereditary disease testing, and prenatal screening with comparable test panels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Germano de Sousa social profiles
Digital presenceGermano de Sousa compliance and trust
Trust signalCompliance2 records
Germano de Sousa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Germano de Sousa leadership team
Management profileNumber of profiles
Profiles1 record
Germano de Sousa funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Germano de Sousa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Germano de Sousa
What does Germano de Sousa do?
Germano de Sousa is a Portuguese clinical pathology laboratory group that delivers diagnostic testing services through a national network of more than 500 patient collection points and three specialized laboratories covering clinical pathology, anatomical pathology, and genetics. Core services include routine clinical analyses, prenatal screening (including NIPT), cytogenetics and genomics research, and anatomopathological diagnostics, with additional corporate occupational health testing and partnerships with the Portuguese National Health Service (SNS) and private insurers.
Is Germano de Sousa a public or private company?
Germano de Sousa is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Germano de Sousa founded?
Germano de Sousa was founded in 1976. It employs 1,001 to 5,000 people.
Where is Germano de Sousa based?
Germano de Sousa is headquartered in Carnide, Portugal, in the Europe region.
How does Germano de Sousa make money?
Five revenue lines are on record. Clinical Pathology Testing Services are the primary driver. The others are genetic Testing Services, anatomical Pathology Services, occupational Medicine Services and home Collection Services.
Who are Germano de Sousa's main competitors?
Broad incumbents on record are Labcorp, CUF, Synlab, Quest Diagnostics, Sonic Healthcare, Affidea and Unilabs. Direct peers are Joaquim Chaves Saúde and Dr. Campos Costa. Eurofins Genoma is listed as an emerging player.
Does Germano de Sousa have an API?
No public API is recorded for Germano de Sousa.
What industry is Germano de Sousa in?
Germano de Sousa's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.